Anti-inflammatory effect of interleukin-10 in rabbit immune complexinduced colitis

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 7, 1998, Pages 754-758

  Grool, T A ^a   Van Dullemen, H ^b   Meenan, J ^b   Koster, F ^b   Ten Kate, F J W ^b   Lebeaut, A ^b   Tytgat, G N J ^b   Van Deventer, S J H ^b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b NONE

Author keywords

Acute colitis; Animal model; Inflammatory bowel disease; Interleukin 10

Indexed keywords

RECOMBINANT INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; IMMUNE COMPLEX DISEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ACUTE DISEASE; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENTEROCOLITIS; INTERLEUKIN-10; INTESTINAL MUCOSA; LEUKOTRIENE B4; MALE; RABBITS; RANDOM ALLOCATION; REFERENCE VALUES;

EID: 0031821859     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850171710     Document Type: Article

References (40)

1. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of il-10 produced by monocytes. J Exp Med 1991;174:1209-20.
2. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. Il-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
3. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mossmann TR. Interleukin-10. Annu Rev Immunol 1993;11: 165-90.
4. O'Garra A, Chang R, Go N, Hastings R, Houghton G, Howard M, Ly-1 B (B-1) cells are the main source of B-cell derived interleukin-10. Eur J Immunol 1992;22:711-7.
5. + T-cell clones and peripheral blood T-cells. J Immunol 1992;149:2378-84.
6. Enk A, Katz SI. Identification and induction of keratinocyte-derived IL-10. J Immunol 1992;149:92-95.
7. Fiorentino DF, Zlotnik A, Viera P, Mosmann TR, Howard M, Moore KW, et al. Il-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146: 3444-51.
8. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915-24.
9. Taga K, Tosato G. Il-10 inhibits human T cell proliferation and IL-2. J Immunol 1992;148:1143-8.
10. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T-helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
11. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207-11.
12. Kasama T, Strieter M, Lukacs N, Burdick M, Kunkel S. Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994;152:3559-69.
13. Wang P, Wu P, Anthes JC, Siegel MI, Egan RW, Billah MM. Interleukin-10 inhibits inlerleukin-8 production in human neutrophils. Blood 1994;83:2678-83.
14. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, Macdermott RP, et al. Enhanced secretion of tumor necrosis factor-alpha. IL-6 and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-81.
15. Schreiber S, Heinig T, Thiele H, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995;108:1434-44.
16. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
17. + T cells. Immunity 1994;1:553-62.
18. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin-10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leucocytes by delaying mRNA degradation. J Exp Med 1994;179:1695-9.
19. Miyazaki I, Cheung RK, Dosch H-M, et al. Viral interleukin-10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J Exp Med 1993;178:439-47.
20. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 1989;30: 835-8.
21. MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflammed human intestine. Clin Exp Immunol 1990;81:301-5.
22. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease - enhanced production during active disease. Gut 1990;31:686-9.
23. Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J Immunol 1995;154:3454-60.
24. Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 1993;151:5666-74.
25. Hogdson HJF, Potter BJ, Skinner J, Jewell DP. Immune-complex mediated colitis in rabbits. Gut 1978;19:225-32.
26. Zipser RD, Nast CC, Lee M, Kao HW, Duke R. In vivo production of leukotriene B4 and leukotriene C4 in rabbit colits. Gastroenterology 1987;92:33-9.
27. Sylvestre DL, Ravetch JV. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 1994; 265:1095-8.
28. Trevani AS, Fontan PA, Andonegui GA, Isturiz MA, Geffner JR. Neutrophil chemotaxis induced by immune complexes. Clin Immunol Immunopathol 1995;74:107-11.
29. Krawisz JE, Sharon P, Stenson WF. Quantitive assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-50.
30. Wallace JL. Eicosanoids. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams and Wilkins; 1994. p. 123-32.
31. Phipps RP, Stein SH, Roper RL. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991; 12:349-52.
32. Cominelli F, Nast CC, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 1992;31:65-71.
33. Hack CE, Eerenberg-Belmer AJM, Hannema AJ, Out TA, Aalberse RC. Polyethylene glycol enhances the binding of C1q to circulating immune complexes. J Immunol Methods 1981; 44:211-21.
34. Meenan J, Grool TA, Hommes DW, Dijkhuizen S, Kate ten FJW, Wood M, et al. Lexipafant (BB882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. Eur J Gastroenterol Hepatol 1996;8:569-73.
35. Meenan J, Hommes DW, Mevissen M, Dijkhuizen S, Soule H, Buller HR, et al. Attenuation of rabbit colitis by neutrophil inhibitory factor, a novel β-integrin inhibitor. Scand J Gastroenterol 1996;31:1007-9.
36. Willems F, Marchant A, Delville JP, Gerard C, Delvaux A, Velu T, et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994;24:1007-9.
37. Ralph P, Nakoinz A, Sampson-Johannes A, Fong S, Lowe D, Min H, et al. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992; 148:808-14.
38. James S. Mucosal immune regulation. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams and Wilkins; 1994. p. 65-77.
39. Schreiber S, Raedler A, Stenson W, Macdermott P. The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol Clin North Am 1992;21:451-502.
40. Yamada T, Grisham MB. Pathogenesis of tissue injury: role of reactive metabolites of oxygen and nitrogen. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams and Wilkins; 1994. p. 133-50.